International Clinical Trial: Standard Testing Pathway for High-Throughput Sequencing in Precision Oncology

Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127957) titled 'Standard Testing Pathway for High-Throughput Sequencing in Precision Oncology' on July 10.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: West China Hospital of Sichuan University

Condition: Non-small cell lung cancer Colorectal cancer

Intervention: Cohort of lung cancer patients:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-15

Target Sample Size: Cohort of lung cancer patients:400;Colorectal cancer patient cohort:400;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=294141

Publish...